FEAM are leading the development of a new SAPEA Evidence Review Report on Cancer screening. Initial scoping and exploratory work for this topic was conducted by FEAM on behalf of SAPEA in 2020 and 2021 and the final scoping paper from the European Commission, which was informed by this work, was published on 4th May 2021.
The European Commission will make a proposal by 2022 to update the Council Recommendation on cancer screening to ensure it reflects the latest available scientific evidence. One of the main objectives will be to consider the extension of cancer screening beyond breast, colorectal and cervical cancers to include prostate, lung and gastric cancer, and other cancers if supported by scientific evidence.
In advance of this proposal, the European Commission’s Group of Chief Scientific Advisors will develop a Scientific Opinion on this important topic and in order to inform this, they have asked SAPEA to produce a new Evidence Review Report.
More information about the process for working on this topic can be accessed here.